Skip to main content
HCPCS Q9956 · Level II · Part B drug

Q9956: octafluoropropane microspheres (Optison), HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q9956

Billing unit
1 ML
Inj octafluoropropane mic,ml
ASP payment limit
$40.323
October 2026; -1.3% vs July 2026
Practitioner MUE
9
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
4
16 states

TL;DR

HCPCS Q9956 is the Level II code for Injection, octafluoropropane microspheres, per ml, billed per 1 ML. The Medicare Part B ASP payment limit for October 2026 is $40.323 per billing unit, down 1.3% from July 2026. The practitioner MUE allows up to 9 units per date of service (MAI 3), so a full 9-unit day is $362.91 at the current limit. Under OPPS it carries status indicator N. Diagnostic agents are usually packaged under OPPS (status N) in the hospital outpatient setting, so separate payment applies mainly in the physician office under Part B. The ASP crosswalk maps 2 NDCs to it, sold as Optison by GE Healthcare Inc. 4 Medicare coverage articles list the code across 15 states plus DC, including A56505.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for Q9956 at $40.323 per 1 ML for October 2026, derived from manufacturer average sales price plus 6%, compared with $40.854 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for Q9956
QuarterPayment limitPerCoinsurance
October 2026$40.3231 ML20%
July 2026$40.8541 ML—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to Q9956. Report the NDC in the claim's drug segment and bill the number of Q9956 units that equals the quantity administered divided by 1 ML; the last column gives units per full package.

NDCs that crosswalk to Q9956
NDCDrug nameLabelerPackage sizeBilling units / package
00407-2707-03OptisonGE Healthcare Inc.3 × 515
00407-2707-18OptisonGE Healthcare Inc.3 × 1854

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q9956. For practitioners the limit is 9 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q9956 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services93 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital93 Date of Service Edit: ClinicalPrescribing Information

MUE for Q9956 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists Q9956 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check Q9956 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q9956 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

4 current Medicare Administrative Contractor articles list Q9956 in their HCPCS tables, covering 16 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing Q9956
ArticleTitleContractor(s)StatesRelated LCD
A56505Billing and Coding: Transesophageal Echocardiography (TEE)Novitas Solutions, Inc.DC DE MD NJ PAL35016
A56781Billing and Coding: Transthoracic Echocardiography (TTE)Wellpoint FederalCT IL MN NY WIL33577
A57306Billing and Coding: Transthoracic Echocardiography (TTE)CGS Administrators, LLCKY OHL34338
A58503Billing and Coding: Echocardiography for Myocardial PerfusionPalmetto GBANC SC VA WVL38786

Diagnoses Medicare contractors cover for Q9956

One billing and coding article attaches a covered diagnosis list to Q9956: 503 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for Q9956
ICD-10-CMDescription (FY2027)Articles covering
A18.84Tuberculosis of heart1 of 1
A40.0Sepsis due to streptococcus, group A1 of 1
A40.1Sepsis due to streptococcus, group B1 of 1
A40.3Sepsis due to Streptococcus pneumoniae1 of 1
A40.8Other streptococcal sepsis1 of 1
A41.01Sepsis due to Methicillin susceptible Staphylococcus aureus1 of 1
A41.02Sepsis due to Methicillin resistant Staphylococcus aureus1 of 1
A41.1Sepsis due to other specified staphylococcus1 of 1
A41.3Sepsis due to Hemophilus influenzae1 of 1
A41.4Sepsis due to anaerobes1 of 1
A41.51Sepsis due to Escherichia coli [E. coli]1 of 1
A41.52Sepsis due to Pseudomonas1 of 1
A41.53Sepsis due to Serratia1 of 1
A41.59Other Gram-negative sepsis1 of 1
A41.81Sepsis due to Enterococcus1 of 1
488 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to Q9956 are counted here: a group whose instructions name Q9956, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to Q9956, by article
ArticleContractorGroups that applyCovered codes for Q9956Full list
A56505Novitas Solutions, Inc.group 1 applies to Q9956503On LCD L35016
A56781Wellpoint Federalgroups are written for 76376, 76377, 93303, 93304 and others—On LCD L33577
A57306CGS Administrators, LLCgroups are written for 76376, 76377, 93303, 93304 and others—On LCD L34338
A58503Palmetto GBAgroups are written for 0439T—On LCD L38786

3 more articles list Q9956 but write their diagnosis groups for other procedure codes in the same article; there the diagnosis has to fit the group written for the procedure billed with the drug.

Local coverage policies that list Q9956

4 active Local Coverage Determinations list Q9956 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q9956 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q9956 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for Q9956 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q9956

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q9956

What does HCPCS code Q9956 describe?

Q9956 is defined by CMS as "Injection, octafluoropropane microspheres, per ml". Each billing unit represents 1 ML, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q9956 a CPT code?

No. Q9956 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as octafluoropropane microspheres (Optison); CPT codes are five-character codes maintained by the AMA. On a Part B claim Q9956 reports the drug itself in 1 ml units, and the administration is billed on its own line.

What is the Medicare reimbursement for Q9956 in October 2026?

The ASP-based payment limit is $40.323 per 1 ML, with 20% beneficiary coinsurance. The July 2026 limit was $40.854. Commercial payers use their own fee schedules.

How many units of Q9956 can be billed per day?

The practitioner Medically Unlikely Edit is 9 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to Q9956?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Optison (GE Healthcare Inc.). For example NDC 00407-2707-03 (package size 3) equals 15 billing units of Q9956.

Does Q9956 have NCCI bundling edits?

No active practitioner PTP pairs list Q9956 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention Q9956?

4 current Billing and Coding Articles in the Medicare Coverage Database list Q9956, covering 15 states plus DC: A56505 (Billing and Coding: Transesophageal Echocardiography (TEE)); A56781 (Billing and Coding: Transthoracic Echocardiography (TTE)); A57306 (Billing and Coding: Transthoracic Echocardiography (TTE)).

What diagnosis codes support Q9956?

One Medicare billing and coding article lists 503 covered ICD-10-CM codes for Q9956, for example A18.84 (Tuberculosis of heart); A40.0 (Sepsis due to streptococcus, group A); A40.1 (Sepsis due to streptococcus, group B); A40.3 (Sepsis due to Streptococcus pneumoniae); A40.8 (Other streptococcal sepsis). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it. 3 more articles tie their diagnosis groups to other procedure codes they list rather than to Q9956.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.